End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,690 KRW | +0.15% | +0.30% | -4.84% |
2023 | Optipharm.CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2022 | Optipharm.CO.,LTD(KOSDAQ:A153710) dropped from S&P Global BMI Index | CI |
Sales 2022 | 16.01B 11.81M 985M | Sales 2023 | 17.37B 12.82M 1.07B | Capitalization | 103B 76.11M 6.35B |
---|---|---|---|---|---|
Net income 2022 | -2.04B -1.51M -126M | Net income 2023 | -2.44B -1.8M -150M | EV / Sales 2022 | 5.87 x |
Net cash position 2022 | 8.9B 6.57M 547M | Net cash position 2023 | 5.6B 4.14M 345M | EV / Sales 2023 | 5.61 x |
P/E ratio 2022 |
-50.2
x | P/E ratio 2023 |
-42.3
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 58.98% |
1 day | +0.15% | ||
1 week | +0.30% | ||
Current month | +0.15% | ||
1 month | -0.45% | ||
3 months | -2.05% | ||
6 months | -5.37% | ||
Current year | -4.84% |
Managers | Title | Age | Since |
---|---|---|---|
Hyun-Il Kim
CEO | Chief Executive Officer | 52 | - |
Ki-Myung Choi
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Beom-Gu Han
BRD | Director/Board Member | 55 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Hyun-Il Kim
CEO | Chief Executive Officer | 52 | - |
Ki-Myung Choi
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Young-Ho Kim
BRD | Director/Board Member | 47 | - |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 6,690 | +0.15% | 10,659 |
02/24/02 | 6,680 | 0.00% | 7,686 |
30/24/30 | 6,680 | +0.15% | 7,584 |
29/24/29 | 6,670 | 0.00% | 7,109 |
26/24/26 | 6,670 | -0.45% | 7,497 |
End-of-day quote Korea S.E., May 03, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-4.84% | 71.51M | |
-9.19% | 6.64B | |
+24.75% | 3.7B | |
-1.11% | 3.12B | |
+6.08% | 1.45B | |
-15.13% | 1.37B | |
-25.63% | 1.24B | |
-7.62% | 1.21B | |
-10.84% | 1.17B | |
-.--% | 1.05B |
- Stock Market
- Equities
- A153710 Stock